Skip to main content

Supportive care and suvivorship

Journal articles and book chapters

01-12-2017 | Breast cancer | Article

Oral curcumin for radiation dermatitis: a URCC NCORP study of 686 breast cancer patients

Ryan Wolf J et al. Support Care Cancer 2017; doi:10.1007/s00520-017-3957-4

23-11-2017 | Leukemia | Article

Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions

Lee SSF, Fulford AE, Quinn MA, Seabrook J & Rajakumar I. Support Care Cancer 2017. doi:10.1007/s00520-017-3976-1

30-10-2017 | Recurrent and metastatic breast cancer | Article

The value of embedding: integrated palliative care for patients with metastatic breast cancer

Rabow M et al. Breast Cancer Res Treat 2017. doi:10.1007/s10549-017-4556-2

23-10-2017 | Colorectal cancer | Article

The effect of physical activity on fatigue among survivors of colorectal cancer: a systematic review and meta-analysis

Brandenbarg D, Korsten JHWM, Berger MY & Berendsen AJ. Support Care Cancer 2018; 26(2):393. doi:10.1007/s00520-017-3920-4

17-10-2017 | Breast cancer | Article

Body mass index (BMI), postoperative appearance satisfaction, and sexual function in breast cancer survivorship

Rojas KE et al. J Cancer Surviv 2017. doi:10.1007/s11764-017-0651-y

30-09-2017 | Prostate cancer | Article

Risk of age-related macular degeneration in patients with prostate cancer: a nationwide, population-based cohort study

Lin SY et al. Ann Oncol 2017; 28(10): 2575-2580. doi:10.1093/annonc/mdx402

18-09-2017 | Pancreatic cancer | Article

What questions are most important to pancreatic cancer patients soon after diagnosis? A multicenter survey

Surveying patients diagnosed with pancreatic cancer in the Netherlands, the authors explore the wide range of questions patients consider most important to address in the weeks following their diagnosis.

Ronde-Schoone LJM et al. Appl Cancer Res 2017; 37: 32. doi:10.1186/s41241-017-0038-4

17-09-2017 | Supportive care | Article

Integrating referral to community-based cancer information and support services in a hospital setting

Marco DJT et al. Support Care Cancer 2018; 26: 787. doi:10.1007/s00520-017-3890-6

17-09-2017 | Multiple myeloma | Article

Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial

In this randomized sham-controlled trial, the authors evaluate the efficacy and safety of acupuncture as an integrative treatment for managing common symptoms during hematopoietic stem cell transplantation in  multiple myeloma patients.

Deng G et al. Support Care Cancer 2017. DOI:10.1007/s00520-017-3881-7

04-09-2017 | Head and neck cancers | Article

Functional and quality of life outcomes after partial glossectomy: a multi-institutional longitudinal study of the head and neck research network

This exploratory study investigates how patients recover their communicative function, swallowing ability, and quality of life after primary surgery for tongue cancer over the first year post-operation.

Dzioba A et al. J of Otolaryngol Head Neck Surg 2017; 46: 56. doi:10.1186/s40463-017-0234-y

01-09-2017 | Uterine cancer | Article

Cardiovascular disease mortality among women with endometrial cancer in the Iowa Women’s Health Study

Examining a prospective cohort study, the authors shed new light on the association between endometrial cancer development and cardiovascular disease mortality. 

Felix AS et al. Cancer Causes Control 2017; 28: 1043-1051. doi:10.1007/s10552-017-0953-4

01-09-2017 | Neuroendocrine tumors | Article

Improving quality of life in patients with pancreatic neuroendocrine tumor following peptide receptor radionuclide therapy assessed by EORTC QLQ-C30

In this study, the authors find peptide receptor radionuclide therapy to be effective in the treatment of pancreatic neuroendocrine tumors whilst also improving the quality of life of patients.

Marinova M, et al. Eur J Nucl Med Mol Imaging 2017. doi:10.1007/s00259-017-3816-z

31-08-2017 | Nausea and vomiting | Article

Is the addition of a neurokinin-1 receptor antagonist beneficial in moderately emetogenic chemotherapy? A systematic review and meta-analysis

This systematic review evaluates the efficacy of adding a neurokinin-1 (NK1) receptor antagonist to a serotonin (5-hydroxytryptamine-3; 5-HT3) receptor antagonist and a steroid for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy.

Jordan K et al. Support Care Cancer 2018. doi: 10.1007/s00520-017-3857-7.

31-08-2017 | Breast cancer | Article

The prevalence of unmet needs in 625 women living beyond a diagnosis of early breast cancer

​​​​​​​Br J Cancer 2017. doi:10.1038/bjc.2017.283

26-08-2017 | Gastrointestinal cancers | Article

Caregiving and mutuality among long-term colorectal cancer survivors with ostomies: qualitative study

Altschuler A, Liljestrand P, Grant M et al. Support Care Cancer 2017. doi:10.1007/s00520-017-3862-x

22-08-2017 | CNS metastases | Article

Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy

Frisk G, et al. Breast Cancer Res Treat 2017. doi:10.1007/s10549-017-4466-3

05-08-2017 | Nausea and vomiting | Review | Article

A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: A focus on pharmacokinetic variability and pharmacodynamics

This review provides an overview of oral cannabinoids, such as dronabinol and nabilone, for the treatment of patients with cancer and chemotherapy-induced nausea and vomiting.

Badowski ME. Cancer Chemother Pharmacol. doi: 10.1007/s00280-017-3387-5